Phase I/II trial of granisetron: A novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting

M. Addelman, C. Erlichman, S. Fine, D. Warr, C. Murray

Research output: Contribution to journalArticle

51 Scopus citations

Fingerprint Dive into the research topics of 'Phase I/II trial of granisetron: A novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting'. Together they form a unique fingerprint.

Medicine & Life Sciences